Prolonged antagonism of morphine-induced locomotor stimulation by κ opioid agonists: Enhancement by prior morphine exposure

Neuroscience Letters

Volumn 213, Issue 1, 1996, Pages 5-8

  Pearl, S M ^a   Glick, S D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Locomotor activity; Morphine; Spiradoline; U50488; Opioid; Opioid

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; SPIRADOLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030602855     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12822-6     Document Type: Article

References (36)

1. [1] Babbini, M. and Davis, W.M., Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment, Br. J. Pharmacol., 46 (1972) 213-224.
2. [2] Bhargava, H.N., Ramarao, P. and Gluati, A., Effects of morphine in rats treated chronically with U-50,488H, a κ opioid receptor agonist, Eur. J. Pharmacol., 162 (1989) 257-264.
3. [3] Craft, R.M. and Dykstra, L.A., Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule, J. Pharmacol. Exp. Ther., 252 (1990) 945-952.
4. [4] Craft, R.M. and Dykstra, L.A., Agonist and antagonist activity of κ opioids in the squirrel monkey: II. Effect of chronic morphine treatment, J. Pharmacol. Exp. Ther., 260 (1992) 334-342.
5. [5] Craft, R.M. and Dykstra, L.A., Morphine antagonizes U50488 effects in a squirrel monkey shock titration procedure, Eur. J. Pharmacol., 234 (1993) 199-207.
6. [6] De Bodo, R.C., The antidiuretic action of morphine and its mechanism, J. Pharmacol. Exp. Ther., 82 (1944) 74-85.
7. [7] Deecher, D.C., Teitler, M., Soderlund, D.M., Bronmann, W.G., Keuhne, M.E. and Glick, S.D., Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies, Brain Res., 571 (1992) 242-247.
8. [8] Devine, D.P., Leone, P., Popock, D. and Wise, R.A., Differential involvement of ventral tegmental μ, δ and κ opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies, J. Pharmacol. Exp. Ther., 266 (1993) 1236-1246.
9. [9] Di Chiara, G. and Imperato, A., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic dopamine system of freely moving rats, Proc. Natl. Acad. Sci. USA, 85 (1988) 5274-5278.
10. [10] Garaulet, J.V., Laorden, M.L. and Milanes, M.V., Cross-tolerance between μ- and κ-opioid agonists in the guinea pig ileum myenteric plexus, J. Pharmacol. Exp. Ther., 269 (1994) 993-999.
11. [11] Green, P.G. and Lee, N.M., Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration, Eur. J. Pharmacol., 145 (1988) 267-272.
12. [12] Gulati, A. and Bhargava, H.N., Up-regulation of brain and spinal cord κ opioid receptors in morphine tolerant-dependent mice, FASEB J., 2 (1988) A368.
13. [13] Hewson, G., Hill, G., Leighton, G.E. and Turner, W.D., The κ agonists PD117302 and U50488 produce a biphasic effect on 24 h food intake in the rat, Neuropharmacology, 26 (1987) 1581-1584.
14. [14] Jones, D.L., Mogenson, G.J. and Wu, M., Injections of dopaminergic, cholinergic, serotonergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat, Neuropharmacology, 20 (1981) 29-37.
15. [15] Joyce, E.M. and Iversen, S.D., The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in mice, Neurosci. Lett., 14 (1979) 207-212.
16. [16] Kunihara, M., Ohyama, M. and Nakano, M., Effects of spiradoline mesylate, a selective κ-opioid receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia, Jpn. J. Pharmacol., 62 (1993) 223-230.
17. [17] Leander, J.D., A κ opioid effects: increased urination in the rat, J. Pharmacol. Exp. Ther., 224 (1983) 89-94.
18. [18] Leighton, G.E., Hill, R.G. and Hughes, J., Effects of 5-HT and α1 adrenoreceptor antagonists on κ opioid-induced sedation, Pharmacol. Biochem. Behav., 31 (1988) 899-904.
19. [19] Maisonneuve, I.M., Rossman, K.L., Keller, Jr., R.W. and Glick, S.D., Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats, Brain Res., 575 (1992) 69-73.
20. [20] Mucha, R.F. and Herz, A., Motivational properties of κ and μ opioid receptor agonists studied with place and taste preference conditioning, Psychopharmacology, 86 (1985) 274-280.
21. [21] Narita, M., Suzuki, T., Misawa, M. and Nagase, H., Antagonism of morphine-induced Straub tail reaction by κ-opioid receptor activation in mice, Psychopharmacology, 110 (1993) 254-256.
22. [22] Pearl, S.M., Herrick-Davis, K., Teitler, M. and Glick, S.D., Radioligand binding study of noribogaine, a likely metabolite of ibogaine, Brain Res., 675 (1995) 342-344.
23. [23] Pearl, S.M., Johnson, D.W. and Glick, S.D., Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation, Psychopharmacology, 121 (1995) 470-475.
24. [24] Pfeiffer, A., Brantl, V., Herz, A. and Emrich, H.M., Psychotomimesis mediated by κ opiate receptors, Science, 233 (1986) 774-776.
25. [25] Picker, M.J., Negus, S.S. and Powell, K.R., Differential cross-tolerance to μ and κ opioid agonists in morphine-tolerant rats responding under a schedule of food presentation, Psychopharmacology, 103 (1991) 129-135.
26. [26] Pijnenberg, A.J.J. and Van Rossum, J.M., Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens, J. Pharm. Pharmacol., 25 (1973) 1003-1005.
27. [27] Ramarao, P., Jablonski, H.I., Rehder, K.R. and Bhargava, H.N., Effect of κ-opioid agonists on morphine analgesia in morphine-naive and morphine-tolerant rats, Eur. J. Pharmacol., 156 (1988) 239-246.
28. [28] Rattan, A.K., Koo, K.L., Tejwani, G.A. and Bhargava, H.N., The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat, Brain Res., 584 (1992) 207-212.
29. [29] Romualdi, P., Lesa, G., Donatini, A., and Ferri, S., Long-term exposure to opioid antagonists up-regulates prodynorphin gene expression in rat brain, Brain Res., 672 (1995) 42-47.
30. [30] Shibata, S., Tominaga, K. and Watanabe, S., κ-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats, Eur. J. Pharmacol., 279 (1995) 197-202.
31. [31] Sofuoglu, M., Portoghese, P.S. and Takemori, A.E., Maintenance of acute morphine tolerance in mice by selective blockage of κ opioid receptors with norbinaltorphimine, Eur. J. Pharmacol., 210 (1992) 159-162.
32. [32] Spanagel, R., Herz, A. and Shippenberg, T.S., Opposing tonically active endogeneous opioid systems modulate the mesolimbic dopaminergic pathway, Proc. Natl. Acad. Sci. USA, 89 (1992) 2046-2050.
33. [33] Spanagel, R. and Shoaib, M., Involvement of mesolimbic κ-opioid systems in the discriminative stimulus effects of morphine, Neuroscience, 63 (1994) 797-804.
34. [34] Spencer, R.L., Hruby, V.J. and Burks, T.F., Body temperature response profiles for selective μ, δ and κ opioid agonists in restrained and unrestrained rats, J. Pharmacol. Exp. Ther., 246 (1988) 92-101.
35. [35] Tulunay, F.C., The effects of morphine and various agonist type analgesics on body temperature in rats, Life Sci., 27 (1980) 511-520.
36. [36] Vasko, M.R. and Domino, E.F., Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetycholine in the rat, J. Pharmacol. Exp. Ther., 207 (1978) 848-858.